IMU-838 and Oseltamivir in treatment of Novel Coronavirus (COVID-19)

Registry ID

EUCTR2020-001805-21

Source registry

EUCTR

Status

GB - no longer in EU/EEA

Phase

PHASE2

Sponsor

University Hospital Coventry & Warwickshire

Start date

2020-05-15

Last update

2026-08-16

Conditions

• Sars-Cov-2

Summary

To evaluate the efficacy of IONIC Intervention (IMU-838 plus Oseltamivir and standard care) vs. Oseltamivir and standard care in adult subjects with COVID-19 in relation to time-to-clinical improvement.

Locations

• , , UK

View on source registry